reference/23039823

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23039823

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	179
issn	1473-3099
issueIdentifier	2
pageRange	169-179
publicationName	The Lancet. Infectious diseases
startingPage	169
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8902a8e7b8a527415b1b258abc7f1b30 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dec46f7acb56735290bbc809033a0e3d
bibliographicCitation	Mulenga V, Musiime V, Kekitiinwa A, Cook AD, Abongomera G, Kenny J, Chabala C, Mirembe G, Asiimwe A, Owen-Powell E, Burger D, McIlleron H, Klein N, Chintu C, Thomason MJ, Kityo C, Walker AS, Gibb DM; CHAPAS-3 trial team. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis. 2016 Feb;16(2):169–79. PMID: 26481928; PMCID: PMC4726762.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1843-8169 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10cb2d34a7fe63f79cd8826e929da8a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad39002fec6541aaea4649ffb4b615ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7509dfb6504536dff212c85932be3d61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba770905c66eb5cce2a1fbd2328c9ac0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cd0c508579b14ee94a45768f360de33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0982-6226 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8794-3674 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1f6e0c260bc8cf1d4001648314fd352 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_089737db81d2d1e5dea7fe9bea4f482d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa6ff22353fb0e4b8213b9f6c70ef51b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_798a0388f8cfbbe4e39fe0ff30639cbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78cebd1cc3486def0a45b109a34379f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5a1b7e361964daa7a4a0abb8887a09a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2e41e078b1313efee3daa0f61313cb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0526c836e4825c61d23d1a5a7c625234 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_593e6dc7de44484a22c205e22b4fd76f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3925-9258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd1e7f5bb1bc44f826e3853668b24788 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dbd14b1b32aefa8c3e741a1624976bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11f6aff023a74004d7b2658079b0e645 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37f30922ca47c85f42ab790241ff59a7
date	201602
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4726762 https://doi.org/10.1016/s1473-3099%2815%2900319-9 https://pubmed.ncbi.nlm.nih.gov/26481928
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27022 https://portal.issn.org/resource/ISSN/1473-3099
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0029429 http://id.nlm.nih.gov/mesh/M0000724 http://id.nlm.nih.gov/mesh/M0461882 http://id.nlm.nih.gov/mesh/M0277557 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0023377 http://id.nlm.nih.gov/mesh/M0027323 http://id.nlm.nih.gov/mesh/M0028682 http://id.nlm.nih.gov/mesh/M0020993 http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0258297 http://id.nlm.nih.gov/mesh/M0023387
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D019380Q000008 http://id.nlm.nih.gov/mesh/D013607Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015024 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D023241 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000480 http://id.nlm.nih.gov/mesh/D019829Q000008 http://id.nlm.nih.gov/mesh/D018119Q000008 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D048588Q000008 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D003521 http://id.nlm.nih.gov/mesh/D019259Q000008 http://id.nlm.nih.gov/mesh/D014454 http://id.nlm.nih.gov/mesh/D015224Q000008 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D015215Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18283 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4463 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8333 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Showing number of triples: 1 to 88 of 88.